Search research articles
Contact Us
Filters
Showing results (21-30 of 243) with videos related to
Page
of 25
Sort By:
Disease Models & Mechanisms
|
August 29, 2022
Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment
Andrew H Miller, Mary C Halloran
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 16, 2016
Pathogen-Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance
Charles L Raison, Andrew H Miller
JAMA Psychiatry
|
April 9, 2015
Are Anti-inflammatory Therapies Viable Treatments for Psychiatric Disorders?: Where the Rubber Meets the Road
Andrew H Miller, Charles L Raison
Psychopharmacology Bulletin
|
October 26, 2002
Antipsychotic-induced hyperprolactinemia and sexual dysfunction
Michael T Compton, Andrew H Miller
Brain, Behavior, and Immunity
|
May 4, 2013
Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias
Charles L Raison, Andrew H Miller
Cerebrum : the Dana Forum on Brain Science
|
October 12, 2013
Do cytokines really sing the blues?
Charles L Raison, Andrew H Miller
Molecular Psychiatry
|
December 2, 2022
Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies
Andrew H Miller, Charles L Raison
The Lancet. Psychiatry
|
September 19, 2020
Trial failures of anti-inflammatory drugs in depression
Andrew H Miller, Carmine M Pariante
The American Journal of Psychiatry
|
August 29, 2003
When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders
Charles L Raison, Andrew H Miller
Biological Psychiatry
|
August 2, 2003
Depression in cancer: new developments regarding diagnosis and treatment
Charles L Raison, Andrew H Miller
Page
of 25
Search research articles
Search
Showing results (21-30 of 243) with videos related to
Sort By:
Page
of 25
Disease Models & Mechanisms
|
August 29, 2022
Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment
Andrew H Miller, Mary C Halloran
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 16, 2016
Pathogen-Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance
Charles L Raison, Andrew H Miller
JAMA Psychiatry
|
April 9, 2015
Are Anti-inflammatory Therapies Viable Treatments for Psychiatric Disorders?: Where the Rubber Meets the Road
Andrew H Miller, Charles L Raison
Psychopharmacology Bulletin
|
October 26, 2002
Antipsychotic-induced hyperprolactinemia and sexual dysfunction
Michael T Compton, Andrew H Miller
Brain, Behavior, and Immunity
|
May 4, 2013
Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias
Charles L Raison, Andrew H Miller
Cerebrum : the Dana Forum on Brain Science
|
October 12, 2013
Do cytokines really sing the blues?
Charles L Raison, Andrew H Miller
Molecular Psychiatry
|
December 2, 2022
Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies
Andrew H Miller, Charles L Raison
The Lancet. Psychiatry
|
September 19, 2020
Trial failures of anti-inflammatory drugs in depression
Andrew H Miller, Carmine M Pariante
The American Journal of Psychiatry
|
August 29, 2003
When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders
Charles L Raison, Andrew H Miller
Biological Psychiatry
|
August 2, 2003
Depression in cancer: new developments regarding diagnosis and treatment
Charles L Raison, Andrew H Miller
Page
of 25